How Amendment Intelligence Helps Reduce Avoidable Protocol Revisions
Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design risks before those risks trigger
clinical trial design
Trial Design in the Time of COVID-19: Complex and Efficient
Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. The current pandemic offers a chance to consider strategies for facilitating adoption of such innovative designs.